000294359 001__ 294359
000294359 005__ 20250108101452.0
000294359 0247_ $$2doi$$a10.1158/1078-0432.CCR-24-2488
000294359 0247_ $$2pmid$$apmid:39466169
000294359 0247_ $$2ISSN$$a1078-0432
000294359 0247_ $$2ISSN$$a1557-3265
000294359 0247_ $$2altmetric$$aaltmetric:169801208
000294359 037__ $$aDKFZ-2024-02192
000294359 041__ $$aEnglish
000294359 082__ $$a610
000294359 1001_ $$00000-0002-9475-0077$$aBrzezinski, Jack J$$b0
000294359 245__ $$aUpdate on surveillance guidelines in emerging Wilms tumor predisposition syndromes.
000294359 260__ $$aPhiladelphia, Pa. [u.a.]$$bAACR$$c2025
000294359 3367_ $$2DRIVER$$aarticle
000294359 3367_ $$2DataCite$$aOutput Types/Journal article
000294359 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1736327665_15914$$xReview Article
000294359 3367_ $$2BibTeX$$aARTICLE
000294359 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000294359 3367_ $$00$$2EndNote$$aJournal Article
000294359 500__ $$a2025 Jan 6;31(1):18-24
000294359 520__ $$aWilms tumors are commonly associated with predisposition syndromes. Many of these syndromes are associated with specific phenotypic features and are discussed in the related paper from the AACR Pediatric Cancer Working Group. Guidelines for surveillance in this population were published in 2017 but since then several studies have identified new genes with recurrent pathogenic variants associated with increased risk for Wilms tumor development. In general, variants in these genes are less likely to be associated with other phenotypic features. Recently, members of the AACR Pediatric Cancer Working Group met to update surveillance guidelines for patients with a predisposition to Wilms tumors with a review of recently published evidence and risk estimates. Risk estimates for Wilms tumor for the more recently described genes are discussed here along with suggested surveillance guidelines for these populations. Several other emerging clinical scenarios associated with Wilms tumor predisposition are also discussed including patients with family histories of Wilms tumor and no identified causative gene, patients with bilateral tumors, and patients with somatic mosaicism for chromosome 11p15.5 alterations. This perspective serves to update pediatric oncologists, geneticists, radiologists, counselors and other healthcare professionals on emerging evidence and harmonize updated surveillance recommendations in the North American and Australian context for patients with emerging forms of Wilms tumor predisposition.
000294359 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000294359 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000294359 7001_ $$00000-0002-1935-5157$$aBecktell, Kerri D$$b1
000294359 7001_ $$00000-0002-1475-0254$$aBougeard, Gaëlle$$b2
000294359 7001_ $$00000-0002-6721-122X$$aBrodeur, Garrett M$$b3
000294359 7001_ $$00000-0002-4073-5509$$aDiller, Lisa R$$b4
000294359 7001_ $$00000-0003-3202-0447$$aDoria, Andrea S$$b5
000294359 7001_ $$00000-0001-7733-383X$$aHansford, Jordan R$$b6
000294359 7001_ $$00000-0002-9134-9640$$aKohlmann, Wendy K$$b7
000294359 7001_ $$00000-0003-4120-5873$$aKratz, Christian P$$b8
000294359 7001_ $$00000-0001-5894-6403$$aMacFarland, Suzanne P$$b9
000294359 7001_ $$0P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aPajtler, Kristian$$b10$$udkfz
000294359 7001_ $$00000-0001-8333-0758$$aRednam, Surya P$$b11
000294359 7001_ $$00000-0003-2543-8378$$aSchienda, Jaclyn$$b12
000294359 7001_ $$00000-0003-0260-3975$$aStates, Lisa J$$b13
000294359 7001_ $$00000-0003-3283-2197$$aVillani, Anita$$b14
000294359 7001_ $$00000-0002-6501-4150$$aWeksberg, Rosanna$$b15
000294359 7001_ $$00000-0003-0970-1850$$aZelley, Kristin$$b16
000294359 7001_ $$00000-0003-2579-1833$$aTomlinson, Gail E$$b17
000294359 7001_ $$00000-0003-1500-9713$$aKalish, Jennifer M$$b18
000294359 773__ $$0PERI:(DE-600)2036787-9$$a10.1158/1078-0432.CCR-24-2488$$n1$$p18-24$$tClinical cancer research$$v31$$x1078-0432$$y2025
000294359 909CO $$ooai:inrepo02.dkfz.de:294359$$pVDB
000294359 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000294359 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000294359 9141_ $$y2024
000294359 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN CANCER RES : 2022$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-25
000294359 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bCLIN CANCER RES : 2022$$d2023-08-25
000294359 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000294359 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000294359 980__ $$ajournal
000294359 980__ $$aVDB
000294359 980__ $$aI:(DE-He78)B062-20160331
000294359 980__ $$aI:(DE-He78)HD01-20160331
000294359 980__ $$aUNRESTRICTED